Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 6Unknown 4Recruiting 4Withdrawn 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 1328Neoplasms 998Carcinoma, Non-Small-Cell Lung 865Prostatic Neoplasms 730Colorectal Neoplasms 671Lung Neoplasms 553Leukemia, Myeloid, Acute 475Neoplasm Metastasis 427Pancreatic Neoplasms 426Carcinoma, Hepatocellular 407Ovarian Neoplasms 393Multiple Myeloma 393Stomach Neoplasms 383Recurrence 369Squamous Cell Carcinoma of Head and Neck 327Melanoma 295Uterine Cervical Neoplasms 288Brain Neoplasms 288Triple Negative Breast Neoplasms 273Glioblastoma 263Head and Neck Neoplasms 260Precursor Cell Lymphoblastic Leukemia-Lymphoma 256Endometrial Neoplasms 238Lymphoma 230Esophageal Neoplasms 226Rectal Neoplasms 224Sarcoma 213Carcinoma, Renal Cell 205Colonic Neoplasms 196Lymphoma, Large B-Cell, Diffuse 194

Interventions

Tirzepatide 1Psilocybin 1Olanzapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Interventional × Opioid-Related Disorders × Clear all
NCT06651177 2026-05-22

TAB

University of Cincinnati

Phase 2 Recruiting
310 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT06574009 2026-05-11

Better Options for Chronic Cancer Pain

VA Office of Research and Development

Phase 4 Recruiting
294 enrolled

Opioid-Related Disorders, Chronic Pain

NCT06200181 2026-02-13

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

M.D. Anderson Cancer Center

Phase 3 Recruiting
87 enrolled

Opioid-Related Disorders

NCT06001749 2025-12-16

Psilocybin in Cancer Pain Study

Dana-Farber Cancer Institute

Phase 2 Recruiting
15 enrolled

Agnosia, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡